17 Jul Evaluating Methodologies for Monitoring Designer Drug Exposure and a Comparison of Results
NASHVILLE, TN. (June 15, 2025) – Dr. Savannah Clary, Clinical Pharmacist at Aegis Sciences Corporation, discusses recent research conducted by Aegis scientists in evaluating differences in presumptive and definitive testing results for urine samples known to contain designer benzodiazepines. This research was presented as a poster presentation at the 2025 NatCon conference. Dr. Clary walks through the poster in this brief video.
If you have further questions about the poster or testing for designer benzodiazepines and other designer drugs, please e-mail info@aegislabs.com.
